← Leaderboards
Anthony J Sinskey
Massachusetts Institute Of Technology
$4,417,604
Attributed
$14,271,834
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2018–23$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
FDA$14,271,834 · 5
By mechanism
U01$9,771,834 · 2
R01$4,500,000 · 3
Top collaborators
- Richard Dean Braatz9 shared
- Stacy Springs9 shared
- Jongyoon Han6 shared
- Rajeev Ram6 shared
- Retsef Levi3 shared
- Ron Weiss3 shared
Grant awards (15)
A modular platform for rapid VLP vaccine development and manufacturing for SARS-CoV-2 pandemic response$500,000
R01 · FY2023 · FD
A modular platform for rapid VLP vaccine development and manufacturing for SARS-CoV-2 pandemic response$500,000
R01 · FY2022 · FD
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases$400,000
R01 · FY2022 · FD
Novel Process Analytic Technology for Continuous Bioprocessses$1,000,000
U01 · FY2021 · FD · contact PI
A modular platform for rapid VLP vaccine development and manufacturing for SARS-CoV-2 pandemic response$500,000
R01 · FY2021 · FD
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases$400,000
R01 · FY2021 · FD
Novel Process Analytic Technology for Continuous Bioprocessses$1,000,000
U01 · FY2020 · FD · contact PI
Smart Data Analytics for Risk Based Regulatory Science and Bioprocessing Decisions$999,979
U01 · FY2020 · FD · contact PI
Continuous Viral Vector Manufacturing based on Mechanistic Modeling and Novel Process Analytics$600,000
R01 · FY2020 · FD · contact PI
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases$400,000
R01 · FY2020 · FD
Novel Process Analytic Technology for Continuous Bioprocessses$2,795,745
U01 · FY2019 · FD · contact PI
Smart Data Analytics for Risk Based Regulatory Science and Bioprocessing Decisions$979,235
U01 · FY2019 · FD · contact PI
Continuous Viral Vector Manufacturing based on Mechanistic Modeling and Novel Process Analytics$600,000
R01 · FY2019 · FD · contact PI
Smart Data Analytics for Risk Based Regulatory Science and Bioprocessing Decisions$2,996,875
U01 · FY2018 · FD · contact PI
Continuous Viral Vector Manufacturing based on Mechanistic Modeling and Novel Process Analytics$600,000
R01 · FY2018 · FD · contact PI